Quick Takeaways
- Adam Koppel has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $22,399,558.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Adam Koppel
- Location
- Boston, MA
- Summary
- The estimated net worth of Adam Koppel is at least $22,399,558 dollars as of 30 Dec 2024. Adam Koppel is the Director, 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $22.31M. Adam Koppel is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $88.3K.
- Signature
- /s /Kristian Humer, Attorney-in-Fact for Adam Koppel
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Adam Koppel and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Solid Biosciences Inc. ($22,311,238).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Adam Koppel
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | Director, 10%+ Owner | $22,311,238 | 11 Jan 2024 | ||
| FHTX | Foghorn Therapeutics Inc. | Director | $88,320 | 29 Dec 2024 | ||
| CERE | Cerevel Therapeutics Holdings, Inc. | Director, 10%+ Owner | $0 | 01 Aug 2024 | ||
| APTX | Aptinyx Inc. | Director, 10%+ Owner | 26 May 2022 | |||
| DRNA | Dicerna Pharmaceuticals Inc | Director | 28 Dec 2021 |
Insider Transactions Reported by Adam Koppel:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.